Lars Kärvestedt

551 total citations
12 papers, 332 citations indexed

About

Lars Kärvestedt is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Lars Kärvestedt has authored 12 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Lars Kärvestedt's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). Lars Kärvestedt is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). Lars Kärvestedt collaborates with scholars based in Sweden, Norway and Denmark. Lars Kärvestedt's co-authors include Kerstin Brismar, Valdemar Grill, Stig Elofsson, Gunvor von Wendt, Anders Hamsten, Harvest F. Gu, Suad Efendić, Jesper Swedenborg, Jonas Malmstedt and S. Efendić and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and Gene.

In The Last Decade

Lars Kärvestedt

12 papers receiving 323 citations

Peers

Lars Kärvestedt
T. Pohlmann Germany
K. Goitom Germany
J. Katz United Kingdom
Mi-Seon Shin South Korea
Robert C. Osburne United States
Ronald J. Graf United States
T. Pohlmann Germany
Lars Kärvestedt
Citations per year, relative to Lars Kärvestedt Lars Kärvestedt (= 1×) peers T. Pohlmann

Countries citing papers authored by Lars Kärvestedt

Since Specialization
Citations

This map shows the geographic impact of Lars Kärvestedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Kärvestedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Kärvestedt more than expected).

Fields of papers citing papers by Lars Kärvestedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Kärvestedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Kärvestedt. The network helps show where Lars Kärvestedt may publish in the future.

Co-authorship network of co-authors of Lars Kärvestedt

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Kärvestedt. A scholar is included among the top collaborators of Lars Kärvestedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Kärvestedt. Lars Kärvestedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Malmstedt, Jonas, Lars Kärvestedt, Jesper Swedenborg, & Kerstin Brismar. (2015). The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovascular Diabetology. 14(1). 93–93. 30 indexed citations
2.
Forsberg, Elisabete, Jacob Grünler, Johan Frostegård, et al.. (2015). Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 29(8). 1152–1158. 13 indexed citations
3.
Lindskog, Magnus, Lars Kärvestedt, & Carl Johan Fürst. (2014). Glycaemic control in end-of-life care. Current Opinion in Supportive and Palliative Care. 8(4). 378–382. 6 indexed citations
4.
Gu, Harvest F., Tianwei Gu, Agneta Hilding, et al.. (2013). Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes. Clinical Epigenetics. 5(1). 20–20. 34 indexed citations
5.
Gu, Harvest F., et al.. (2011). Evaluation of Sox2 genetic effect on the development of type 2 diabetes. Gene. 486(1-2). 94–96. 2 indexed citations
6.
Kärvestedt, Lars, Valdemar Grill, Stig Elofsson, et al.. (2010). The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. Journal of Diabetes and its Complications. 25(2). 97–106. 55 indexed citations
7.
Kärvestedt, Lars, Valdemar Grill, Stig Elofsson, et al.. (2008). Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy. Diabetes Care. 32(2). 317–322. 71 indexed citations
8.
Strawbridge, Rona J., Lars Kärvestedt, Chunde Li, et al.. (2007). GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder. Growth Hormone & IGF Research. 17(5). 392–398. 30 indexed citations
9.
Heald, Adrian, Lars Kärvestedt, Simon Anderson, et al.. (2006). Low Insulin-like Growth Factor-II Levels Predict Weight Gain in Normal Weight Subjects with Type 2 Diabetes. The American Journal of Medicine. 119(2). 167.e9–167.e15. 28 indexed citations
10.
Strawbridge, Rona J., et al.. (2006). P-12 INFLUENCE OF EXON 3-DELETED GROWTH HORMONE RECEPTOR VARIANT ON CLINICAL PARAMETERS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Growth Hormone & IGF Research. 16. S43–S43. 1 indexed citations
11.
Ding, Bo, et al.. (2005). Leu7Pro Polymorphism in the Neuropeptide Y (NPY) Gene is Associated with Impaired Glucose Tolerance and Type 2 Diabetes in Swedish Men. Experimental and Clinical Endocrinology & Diabetes. 113(5). 282–287. 44 indexed citations
12.
Kärvestedt, Lars, Göran Andersson, Suad Efendić, & Valdemar Grill. (2002). A rapid increase in β‐cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment. Journal of Internal Medicine. 251(4). 307–316. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026